Non-myeloablative allogeneic hematopoietic stem cell transplantation.

Area of Science:

• Hematology
• Oncology
• Transplantation Medicine

Background:

• Nonmyeloablative stem cell transplantation (SCT) presents an alternative to conventional myeloablative approaches.
• It expands eligibility for allogeneic transplantation to a broader patient demographic.

Purpose of the Study:

• To review the literature on nonmyeloablative SCT.
• To define its unique characteristics and applicable patient populations.

Main Methods:

• Literature review of research studies.
• Analysis of research and clinical reviews.
• Inclusion of clinical experience.

Main Results:

• Nonmyeloablative SCT is effective and safe in heterogeneous patient groups.
• Distinct engraftment kinetics, patient selection criteria, and complication profiles compared to myeloablative SCT.

Conclusions:

• Nonmyeloablative SCT is a viable option for patients previously excluded from allogeneic transplantation.
• Nurses require specific knowledge for individualized care of diverse patients, including elderly individuals and those with comorbidities.